medigraphic.com
ISSN 1561-3011 (Electronic)

2021, Number 2

<< Back Next >>

Rev Cubana Invest Bioméd 2021; 40 (2)

Clinical-epidemiological characteristics of patients affected by COVID-19 residing in Havana

Roblejo BH, Benítez CY, Álvarez GY, Bravo RM, Pereira RN, García GD, Sotomayor LF, Monzón BG, Zúñiga RY, Romero CRY, Morales PE, Silva ALC, Marcheco TB

Language: Spanish
References: 20
Page: 1-19
PDF size: 463.21 Kb.


ABSTRACT

Introduction: Havana city was the most complex territory at the national level facingthe first outbreak of COVID-19. Its condition of capital, the population density, the limited geographical delimitation between its municipalities, the high inter-municipal and inter-provincial flow of people, added to the fact that it is the province that receives the largest number of travelers from abroad, conferred particularities on this territory.
Objective: To determine the main clinical-epidemiological characteristics of patients affected by COVID-19 living in Havana.
Methods: An observational, analytical, cross-sectional study was carried out. The sample contained 431 patients, older than one year, with epidemiological discharge from the SARS-CoV-2 infection. To collect information, a questionnaire was applied through an interview.
Results: The average age of the sample was 45 years. More than half of the cases evolved in a symptomatic way (not serious or serious). Fever was the most frequent clinical manifestation. The individuals included in the sample, with blood group O or with a background of asthma, showed less risk of presenting symptomatic forms of the disease.
Conclusions: The results suggest that age is the main risk factor for developing symptomatic forms (not severe or severe) of COVID-19. On the contrary, blood group O and a history of asthma are protective factors for these forms of clinical evolution.


REFERENCES

  1. Euro Surveillance Editorial Team. Note from the editors: novel coronavirus (2019-nCoV). Euro Surveill. 2020;25(3):2001231. PMID: 31992390

  2. Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020;395(10223):497-506.

  3. Ge H, Wang X, Yuan X, Xiao G, Wang C, Deng T,et al. The epidemiology and clinical information about COVID-19. Eur J Clin Microbiol Infect Dis. 2020;39(6):1011-9. PMID: 32291542

  4. Harapan H, Itoh N, Yufika A, Winardi W, Keam S, Te H, et al. Coronavirus disease 2019 (COVID-19): A literature review. J Infect Public Health. 2020;13(5):667-73. PMID: 32340833

  5. Perez Abreu MR, Gomez Tejeda JJ, Dieguez Guach RA. Características clínico-epidemiológicas de la COVID-19. Revista Habanera de Ciencias Médicas. 2020 [acceso: 29/10/2020];19(2). Disponible en: http://www.revhabanera.sld.cu/index.php/rhab/article/view/3254

  6. Dai X. ABO blood group predisposes to COVID-19 severity and cardiovascular diseases. European Journal of Preventive Cardiology. 2020 sep 1;27(13). DOI: 10.1177/2047487320922370

  7. Pérez Rodríguez Nd, Remond Noa R, Torres Reyes A, Veranes Miranda A, Fernández Lorenzo JM, Oviedo Álvarez V, et al. Distribución de la población vulnerable a la enfermedad COVID-19 en La Habana, Cuba. Rev Cubana Hig Epidemiol. 2020 [acceso: 29/10/2020]; 57. Disponible en: http://www.revepidemiologia.sld.cu/index.php/hie/article/view/371

  8. Plasencia-Urizarri TM, Aguilera-Rodríguez R, Almaguer Mederos LE. Comorbilidades y gravedad clínica de la COVID-19: revisión sistemática y meta-análisis. Revista Habanera de Ciencias Médicas. 2020 [acceso: 29/10/2020];19. Disponible en: http://www.revhabanera.sld.cu/index.php/rhab/article/view/3389

  9. Garibaldi BT, Fiksel J, Muschelli J, Robinson ML, Rouhizadeh M, Perin J, et al. Patient Trajectories Among Persons Hospitalized for COVID-19: A Cohort Study. Ann Intern Med. 2020 Sep 22: M20-3905. PMID: 32960645

  10. Li LQ, Huang T, Wang YQ, Wang ZP, Liang Y, Huang TB, et al. COVID-19 patients' clinical characteristics, discharge rate, and fatality rate of meta-analysis. J Med Virol. 2020;92(6):577-83. PMID: 32162702

  11. Korean Society of Infectious Diseases, Korean Society of Pediatric Infectious Diseases, Korean Society of Epidemiology, Korean Society for Antimicrobial Therapy, Korean Society for Healthcare-associated Infection Control and Prevention, Korea Centers for Disease Control and Prevention. Report on the Epidemiological Features of Coronavirus Disease 2019 (COVID-19) Outbreak in the Republic of Korea from January 19 to March 2, 2020. J Korean Med Sci. 2020;35(10):e112. PMID: 32174069

  12. Kopel J, Perisetti A, Roghani A, Aziz M, Gajendran M, Goyal H. Racial and Gender-Based Differences in COVID-19. Front PublicHealth. 2020;8:418. PMID: 32850607

  13. Cuba. Oficina Nacional de Estadística, Centro de Estudios de Población y Desarrollo.El color de la piel según el censo de población y viviendas de 2012.La Habana: ONEI; 2016. [acceso:08/09/2020]. Disponible en: http://www.onei.gob.cu/sites/default/files/publicacion_completa_color_de_la_piel__0.pdf

  14. Buitrago-Garcia D, Egli-Gany D, Counotte MJ, Hossmann S, Imeri H, Ipekci AM, et al. Occurrence and transmission potential of asymptomatic and presymptomatic SARS-CoV-2 infections: A living systematic review and meta-analysis. PLoS Med. 2020;17(9):e1003346. PMID: 32960881

  15. Lechien JR, Chiesa-Estomba CM, De Siati DR, Horoi M, Le Bon SD, Rodriguez A, et al. Olfactory and gustatory dysfunctions as a clinical presentation of mild-to-moderate forms of the coronavirus disease (COVID-19): a multicenter European study. Eur Arch Otorhinolaryngol. 2020;277(8):2251-61. PMID: 32253535

  16. Medina-Fuentes G, Carbajales-León EB, Figueredo-González Y, Carbajales-León AI, Silva-Corona I. Características clínicas y epidemiológicas de los pacientes positivos a la COVID-19 de la provincia Camagüey. Rev. electron. Zoilo. 2020 [acceso: 30/10/2020]; 45(6). Disponible en: http://revzoilomarinello.sld.cu/index.php/zmv/article/view/2363

  17. Giralt-Herrera A, Rojas-Velázquez JM, Leiva-Enríquez J. Relación entre COVID-19 e Hipertensión Arterial. Revista Habanera de Ciencias Médicas. 2020 [acceso:30/10/2020]; 19(2). Disponible en: http://www.revhabanera.sld.cu/index.php/rhab/article/view/3246

  18. Gérard C, Maggipinto G, Minon JM. COVID-19 and ABO blood group: another viewpoint. Br J Haematol. 2020;190(2):e93-4. PMID: 32453863

  19. Perrotta F, Corbi G, Mazzeo G, Boccia M, Aronne L, D'Agnano V. Correction to: COVID-19 and the elderly patients: insights into pathogenesis and clinical decision-making. Aging Clin Exp Res. 2020;32(9):1909. Erratum for: Aging Clin Exp Res. 2020;32(8):1599-608. PMID: 32902821

  20. Liu S, Zhi Y, Ying S. COVID-19 and Asthma: Reflection Duringthe Pandemic. Clin Rev Allergy Immunol. 2020;59(1):78-88. PMID: 32468411




2020     |     www.medigraphic.com